IP Verse

Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan

Patent No. EP3919048 (titled "Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan") was filed by Ipsen Biopharm on Jun 12, 2013. The application was issued on Jan 28, 2026.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LEPTHIENOct 28, 2026GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
GENERICS UKOct 27, 2026ELKINGTON AND FIFE
SANDOZOct 27, 2026KRAUS & LEDERER PARTGMBB
TEVA PHARMACEUTICAL INDUSTRIES LTDOct 27, 2026D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3919048

IPSEN BIOPHARM
Application Number
EP21171689A
Filing Date
Jun 12, 2013
Status
Granted And Under Opposition
Dec 26, 2025
Publication Date
Jan 28, 2026
External Links
Slate, Register , Google Patents